Lihe Lu

1.8k total citations · 2 hit papers
30 papers, 1.4k citations indexed

About

Lihe Lu is a scholar working on Molecular Biology, Cell Biology and Nephrology. According to data from OpenAlex, Lihe Lu has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Nephrology. Recurrent topics in Lihe Lu's work include Parathyroid Disorders and Treatments (6 papers), Caveolin-1 and cellular processes (4 papers) and Bone Metabolism and Diseases (4 papers). Lihe Lu is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Caveolin-1 and cellular processes (4 papers) and Bone Metabolism and Diseases (4 papers). Lihe Lu collaborates with scholars based in China, Japan and Macao. Lihe Lu's co-authors include Jianyun Yan, Yining Li, Xiaoyu Liu, Huimin Yu, Qingchun Liang, Jing‐Song Ou, An Chen, WU Wei-kang, Qianqian Dong and Mingwei Fu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Lihe Lu

30 papers receiving 1.4k citations

Hit Papers

Repression of the antiporter SLC7A11/glutathione/glutathi... 2020 2026 2022 2024 2022 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihe Lu China 19 648 284 257 250 205 30 1.4k
Yuki Izawa‐Ishizawa Japan 23 421 0.6× 223 0.8× 178 0.7× 179 0.7× 120 0.6× 76 1.5k
Xiubin Liang China 22 855 1.3× 170 0.6× 255 1.0× 121 0.5× 268 1.3× 62 1.5k
He-He Hu China 11 554 0.9× 273 1.0× 128 0.5× 129 0.5× 173 0.8× 14 1.3k
Zhen Qiu China 14 784 1.2× 280 1.0× 195 0.8× 125 0.5× 109 0.5× 38 1.2k
Mirjana Jerkić Canada 26 523 0.8× 414 1.5× 158 0.6× 161 0.6× 137 0.7× 46 1.6k
Jun Ni China 22 680 1.0× 117 0.4× 180 0.7× 149 0.6× 210 1.0× 58 1.6k
Raquel Rodrigues‐Díez Spain 25 730 1.1× 190 0.7× 128 0.5× 206 0.8× 311 1.5× 45 1.6k
Ming‐Jiang Xu China 22 626 1.0× 148 0.5× 194 0.8× 150 0.6× 458 2.2× 37 1.7k
Li Gao China 23 725 1.1× 301 1.1× 253 1.0× 82 0.3× 364 1.8× 68 1.6k
Hui Lin China 22 642 1.0× 121 0.4× 179 0.7× 405 1.6× 122 0.6× 73 1.4k

Countries citing papers authored by Lihe Lu

Since Specialization
Citations

This map shows the geographic impact of Lihe Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihe Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihe Lu more than expected).

Fields of papers citing papers by Lihe Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihe Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihe Lu. The network helps show where Lihe Lu may publish in the future.

Co-authorship network of co-authors of Lihe Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lihe Lu. A scholar is included among the top collaborators of Lihe Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihe Lu. Lihe Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Lihe, Yining Li, Qian Dong, et al.. (2023). Wogonin inhibits oxidative stress and vascular calcification via modulation of heme oxygenase-1. European Journal of Pharmacology. 958. 176070–176070. 14 indexed citations
2.
Ma, Wenyong, et al.. (2023). The effects of row spacing and ground clearance on the wind load of photovoltaic (PV) arrays. Renewable Energy. 220. 119627–119627. 18 indexed citations
3.
Wang, Siyi, Li Li, Qingchun Liang, et al.. (2022). Deletion of SIRT6 in vascular smooth muscle cells facilitates vascular calcification via suppression of DNA damage repair. Journal of Molecular and Cellular Cardiology. 173. 154–168. 17 indexed citations
4.
Ye, Yuanzhi, An Chen, Li Li, et al.. (2022). Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney International. 102(6). 1259–1275. 238 indexed citations breakdown →
5.
Chen, An, Qingchun Liang, Qianqian Dong, et al.. (2021). Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease. Free Radical Biology and Medicine. 172. 530–540. 44 indexed citations
6.
Dong, Qian, Qingchun Liang, Ying Chen, et al.. (2021). Bibliometric and Visual Analysis of Vascular Calcification Research. Frontiers in Pharmacology. 12. 690392–690392. 32 indexed citations
7.
Chen, Yanting, et al.. (2020). Fuzi Polysaccharide Inhibits VascularSmooth Muscle Cell Calcification via Ceramide Signaling. Journal of Sun Yat-sen University. 41(1). 69. 2 indexed citations
8.
Dong, Qianqian, Yanting Chen, Wantao Liu, et al.. (2020). 25-Hydroxycholesterol promotes vascular calcification via activation of endoplasmic reticulum stress. European Journal of Pharmacology. 880. 173165–173165. 25 indexed citations
9.
Li, Zehua, Wu Ji, Xiuli Zhang, et al.. (2019). CDC42 promotes vascular calcification in chronic kidney disease. The Journal of Pathology. 249(4). 461–471. 42 indexed citations
10.
Kong, Yonglun, Qingchun Liang, Yanting Chen, et al.. (2018). Hyaluronan negatively regulates vascular calcification involving BMP2 signaling. Laboratory Investigation. 98(10). 1320–1332. 28 indexed citations
11.
Lü, Shun, Hao Liu, Lihe Lu, et al.. (2016). WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway. European Journal of Pharmacology. 788. 90–97. 26 indexed citations
12.
Song, Yan, Chufan Luo, Jing‐Song Ou, et al.. (2016). TLR4/NF-κB/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells. European Journal of Pharmacology. 794. 45–51. 78 indexed citations
13.
Song, Yan, Chufan Luo, Jing‐Song Ou, et al.. (2016). Curcumin attenuates osteogenic differentiation and calcification of rat vascular smooth muscle cells. Molecular and Cellular Biochemistry. 420(1-2). 151–160. 34 indexed citations
14.
Li, Yi, Daya Yang, Lihe Lu, et al.. (2015). Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention. Canadian Journal of Cardiology. 31(8). 989–997. 22 indexed citations
15.
Yan, Jianyun, et al.. (2015). [High glucose promotes vascular smooth muscle cell calcification by activating WNT signaling pathway].. PubMed. 35(1). 29–33. 9 indexed citations
16.
Liao, Lizhen, Qin Zhou, Yan Song, et al.. (2013). Ceramide Mediates Ox-LDL-Induced Human Vascular Smooth Muscle Cell Calcification via p38 Mitogen-Activated Protein Kinase Signaling. PLoS ONE. 8(12). e82379–e82379. 60 indexed citations
17.
Liu, Xiaofeng, Lihe Lu, Hua Wang, et al.. (2013). Synthesis and Biological Evaluation of Novel Hydroxylphenethyl-S-DACOs as High Active Anti-HIV Agents. Letters in Drug Design & Discovery. 10(3). 271–276. 1 indexed citations
18.
Lu, Lihe, WU Wei-kang, Jianyun Yan, et al.. (2008). Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. International Journal of Cardiology. 134(1). 82–90. 148 indexed citations
19.
Wu, Wei-Kang, Hongmei Tan, Zhi Wang, et al.. (2008). Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms. Toxicology. 247(2-3). 133–138. 98 indexed citations
20.
Jing, Zhi‐Cheng, et al.. (2004). Bone morphogenetic protein receptor-II mutation Arg491Trp causes malignant phenotype of familial primary pulmonary hypertension. Biochemical and Biophysical Research Communications. 315(4). 1033–1038. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026